Metabolic Syndrome, Central Obesity and Insulin Resistance are Associated with Adverse Pathological Features in Postmenopausal Breast Cancer

被引:119
|
作者
Healy, L. A. [1 ,2 ]
Ryan, A. M. [1 ,2 ]
Carroll, P. [2 ,3 ]
Ennis, D. [2 ,3 ]
Crowley, V. [2 ,4 ]
Boyle, T. [2 ,3 ]
Kennedy, M. J. [2 ,5 ]
Connolly, E. [2 ,3 ]
Reynolds, J. V. [2 ,3 ]
机构
[1] St James Hosp, Dept Clin Nutr, Dublin 8, Ireland
[2] Univ Dublin Trinity Coll, Dublin 2, Ireland
[3] St James Hosp, Dept Surg, Dublin 8, Ireland
[4] St James Hosp, Dept Clin Chem, Dublin 8, Ireland
[5] St James Hosp, Acad Unit Clin & Med Oncol, Dublin 8, Ireland
关键词
Breast cancer; metabolic syndrome; obesity; postmenopausal; tumour pathology; BODY-MASS INDEX; RECEPTOR EXPRESSION; SEX-HORMONES; RISK-FACTOR; C-PEPTIDE; WOMEN; SIZE; POPULATION; PREVALENCE; MORTALITY;
D O I
10.1016/j.clon.2010.02.001
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Aims: Obesity is associated with both an increased risk of postmenopausal breast cancer and increased mortality rates. The mechanism is unclear, and central (visceral) obesity, insulin resistance, altered sex steroids and altered adipokines are mooted as possible factors. These features may cluster in the so-called metabolic syndrome. The relevance of metabolic syndrome to the biology of breast cancer is unknown, and this was the focus of the present study. Materials and methods: All postmenopausal women with newly diagnosed breast cancer (n = 105) were recruited. A detailed clinical history was carried out, as well as a body composition analysis, metabolic screen and measurement of adipokines and inflammatory markers. Results: The median age was 68 years (40-94 years) and the mean body mass index was 28.3 +/- 5.2 kg/m(2), with 87% of patients centrally obese. Metabolic syndrome was diagnosed in 39% of patients, and was significantly associated with central obesity (P < 0.005) and increased inflammation, with C-reactive protein levels doubling in metabolic syndrome patients compared with non-metabolic syndrome patients (10.3 vs 5.8 mg/l; P = 0.084). Patients with a later pathological stage (II-IV) were significantly more likely to be obese (P = 0.007), centrally obese (P = 0.009), hyperglycaemic (P = 0.047) and hyperinsulinaemic (P = 0.026); 51% had metabolic syndrome compared with 12% for early stage disease. Patients with node-positive disease were significantly more likely to be hyperinsulaemic (P = 0.030) and have metabolic syndrome (P = 0.028) than patients with node-negative disease. Discussion: The data suggest that metabolic syndrome and central obesity are common in postmenopausal breast cancer patients, and that metabolic syndrome may be associated with a more aggressive tumour biology. (C) 2010 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:281 / 288
页数:8
相关论文
共 50 条
  • [41] Obesity and insulin resistance in breast cancer - Chemoprevention strategies with a focus on metformin
    Goodwin, Pamela J.
    Stambolic, Vuk
    BREAST, 2011, 20 : S31 - S35
  • [42] POSTMENOPAUSAL ESTROGEN RECEPTOR POSITIVE BREAST CANCER AND OBESITY ASSOCIATED GENE VARIANTS
    Ozgoz, Asuman
    Icduygu, Fadime Mutlu
    Yukselturk, Aysegul
    Samli, Hale
    Ozturk, Kuyas Hekimler
    Baskan, Zuhal
    Tutuncu, Ilknur
    EXCLI JOURNAL, 2021, 20 : 1133 - 1144
  • [43] Elevated interleukin-18 levels are associated with the metabolic syndrome independent of obesity and insulin resistance
    Hung, J
    McQuillan, BM
    Chapman, CML
    Thompson, PL
    Beilby, JP
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2005, 25 (06) : 1268 - 1273
  • [44] The Interactions of Obesity, Inflammation and Insulin Resistance in Breast Cancer
    Rose, David P.
    Gracheck, Peter J.
    Vona-Davis, Linda
    CANCERS, 2015, 7 (04): : 2147 - 2168
  • [45] Metabolic syndrome and risk of breast cancer mortality by menopause, obesity, and subtype
    Dibaba, Daniel T.
    Ogunsina, Kemi
    Braithwaite, Dejana
    Akinyemiju, Tomi
    BREAST CANCER RESEARCH AND TREATMENT, 2019, 174 (01) : 209 - 218
  • [46] Metabolic syndrome in postmenopausal breast cancer survivors
    Petri Nahas, Eliana Aguiar
    de Almeida, Bruno da Rosa
    Brito Buttros, Daniel de Araujo
    Vespoli, Helloisa De Luca
    Uemura, Gilberto
    Nahas-Neto, Jorge
    REVISTA BRASILEIRA DE GINECOLOGIA E OBSTETRICIA, 2012, 34 (12): : 555 - 562
  • [47] A Longitudinal Study of the Metabolic Syndrome and Risk of Postmenopausal Breast Cancer
    Kabat, Geoffrey C.
    Kim, Mimi
    Chlebowski, Rowan T.
    Khandekar, Janu
    Ko, Marcia G.
    McTiernan, Anne
    Neuhouser, Marian L.
    Parker, Donna R.
    Shikany, James M.
    Stefanick, Marcia L.
    Thomson, Cynthia A.
    Rohan, Thomas E.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2009, 18 (07) : 2046 - 2053
  • [48] Afamin serum concentrations are associated with insulin resistance and metabolic syndrome in polycystic ovary syndrome
    Seeber, Beata
    Morandell, Elisabeth
    Lunger, Fabian
    Wildt, Ludwig
    Dieplinger, Hans
    REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY, 2014, 12
  • [49] High Prevalence of Metabolic Syndrome and of Insulin Resistance in Psoriatic Arthritis Is Associated with the Severity of Underlying Disease
    Haroon, Muhammad
    Gallagher, Phil
    Heffernan, Eric
    FitzGerald, Oliver
    JOURNAL OF RHEUMATOLOGY, 2014, 41 (07) : 1357 - 1365
  • [50] Visceral obesity predicts adverse pathological features in urothelial bladder cancer patients undergoing radical cystectomy: a retrospective cohort study
    Cantiello, Francesco
    Cicione, Antonio
    Autorino, Riccardo
    Salonia, Andrea
    Briganti, Alberto
    Ferro, Matteo
    De Domenico, Renato
    Perdona, Sisto
    Damiano, Rocco
    WORLD JOURNAL OF UROLOGY, 2014, 32 (02) : 559 - 564